LTD Aversi Clinic
About LTD Aversi Clinic
"The leading multi-profile medical-diagnostic institution in Caucasus region, which is equipped with the newest medical equipment in the world. The hospital has started functioning in 2007 and today, it unites 12 branches and 19 laboratories throughout Georgia."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Celgene
6
H. Lundbeck A/S
6
Pfizer
3
Arena Pharmaceuticals
2
Janssen Research & Development, LLC
2
Optinose US Inc.
2
Actelion
1
Aravive, Inc.
1
Aversi Clinic
1
Berlin-Chemie AG Menarini Group
1
EirGenix, Inc.
1
Clinical Trials at LTD Aversi Clinic
During the past decade, LTD Aversi Clinic conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 11 clinical trials were completed, i.e. on
average, 35.5% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 9 clinical trials were completed. i.e. 64.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy of Bemiparin Versus Enoxaparin in the Treatment of DVT
2013-06-01
2015-05-01
Completed
312
Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections
2014-10-06
2015-08-21
Completed
908
Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)
2014-12-03
2016-12-22
Completed
1,346
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
2015-06-17
2020-06-17
Completed
1,012
An Efficacy and Safety Study of Intravenous Palonosetron Administered as an Infusion and as a Bolus for the Prevention of Nausea and Vomiting
2015-10-01
2016-03-01
Completed
441
A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis
2015-10-16
2023-01-05
Completed
2,350
Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis
2017-07-05
2024-01-18
Active, not recruiting
877
A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
2018-02-06
2020-02-27
Completed
627
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "LTD Aversi Clinic" #1 sponsor was "Celgene" with 6 trials, followed by "H. Lundbeck A/S" with 6 trials
sponsored, "Pfizer" with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "Janssen Research & Development, LLC"
with 2 trials sponsored. Other sponsors include 10 different institutions and
companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "LTD Aversi Clinic"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 3 trials as a collaborator, "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator and "PSI CRO" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at LTD Aversi Clinic
According to Clinical.Site data, the most researched conditions in "LTD Aversi Clinic" are
"Ulcerative Colitis" (6 trials), "Migraine" (5 trials), "Multiple Sclerosis" (4 trials), "Crohn Disease" (3 trials) and "Chronic Rhinosinusitis" (2 trials). Many other conditions were trialed in "LTD Aversi Clinic" in a lesser frequency.
Clinical Trials Intervention Types at LTD Aversi Clinic
Most popular intervention types in "LTD Aversi Clinic" are "Drug" (33 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (19 trials), "Eptinezumab" (5 trials), "Etrasimod" (5 trials), "Ozanimod" (4 trials) and "Guselkumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at LTD Aversi Clinic
The vast majority of trials in "LTD Aversi Clinic" are
32 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at LTD Aversi Clinic
Currently, there are NaN active trials in "LTD Aversi Clinic".
undefined are not yet recruiting,
10 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 19 completed trials in LTD Aversi Clinic,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in LTD Aversi Clinic, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 28 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".